FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3168291254> ?p ?o ?g. }

• W3168291254 abstract "Abstract Background and Aims Vascular calcification is an independent predict factor of cardiovascular mortality and all-cause mortality in chronic kidney disease (CKD) patients. Animals experiments and clinical studies showed the inhibition effect of diphosphonates in vascular calcification, but the results of the studies remains controversial. This meta-analysis aims to evaluate the effects of diphosphonates on vascular calcification in patients with CKD. Method Randomized controlled trials (RCT) and non-RCTs of diphosphonates for the treatment of vascular calcification in CKD patients until September 2020 were searched in the database of PubMed, Embase, Cochrane library, CNKI and Wanfang. Literatures were screened according to the inclusion and exclusion criteria and quality was evaluated by two investigators independently. The standard deviation from mean (SMD) and 95% confidence interval (CI) were used to representthe counting data. Data extracted from the literatures were analyzed with Stata software (version 15.0). Results A total of 6 RCTs and 1 non-RCT with 272 patients were included, characteristics of the studies included are shown in Table 1. Meta-analysis indicated that diphosphonates inhibit vascular calcification in CKD [SMD =-0.297, 95% CI = (-0.591, -0.002), P = 0.049] (Figure 1). Etidronate is the most effective one in treating with vascular calcification (P = 0.020) (Figure 2). But there isn’t significant difference in aortic artery calcification and coronary artery calcification compared with the control group (P&gt;0.05). There was no statistically significant difference in the change of blood calcium, blood phosphate, and serum parathyroid hormone between two groups (all P&gt;0.05). Conclusion Diphosphonates can inhibit the progression of vascular calcification in CKD patients, and it hasn’t obvious effect on blood calcium, blood phosphate, and serum parathyroid hormone. Etidronate is the most promising therapeutic agent." @default.
• W3168291254 created "2021-06-22" @default.
• W3168291254 creator A5009310956 @default.
• W3168291254 creator A5013985623 @default.
• W3168291254 creator A5030190852 @default.
• W3168291254 creator A5048566863 @default.
• W3168291254 creator A5077557437 @default.
• W3168291254 date "2021-05-01" @default.
• W3168291254 modified "2023-09-23" @default.
• W3168291254 title "MO740EFFECT OF DIPHOSPHONATES FOR VASCULAR CALCIFICATION IN CHRONIC KIDNEY DISEASE: A META-ANALYSIS" @default.
• W3168291254 doi "https://doi.org/10.1093/ndt/gfab097.0020" @default.
• W3168291254 hasPublicationYear "2021" @default.
• W3168291254 type Work @default.
• W3168291254 sameAs 3168291254 @default.
• W3168291254 citedByCount "0" @default.
• W3168291254 crossrefType "journal-article" @default.
• W3168291254 hasAuthorship W3168291254A5009310956 @default.
• W3168291254 hasAuthorship W3168291254A5013985623 @default.
• W3168291254 hasAuthorship W3168291254A5030190852 @default.
• W3168291254 hasAuthorship W3168291254A5048566863 @default.
• W3168291254 hasAuthorship W3168291254A5077557437 @default.
• W3168291254 hasConcept C126322002 @default.
• W3168291254 hasConcept C168563851 @default.
• W3168291254 hasConcept C2776478404 @default.
• W3168291254 hasConcept C2778653478 @default.
• W3168291254 hasConcept C2780309369 @default.
• W3168291254 hasConcept C2908539429 @default.
• W3168291254 hasConcept C44249647 @default.
• W3168291254 hasConcept C673006 @default.
• W3168291254 hasConcept C71924100 @default.
• W3168291254 hasConcept C90924648 @default.
• W3168291254 hasConcept C95190672 @default.
• W3168291254 hasConceptScore W3168291254C126322002 @default.
• W3168291254 hasConceptScore W3168291254C168563851 @default.
• W3168291254 hasConceptScore W3168291254C2776478404 @default.
• W3168291254 hasConceptScore W3168291254C2778653478 @default.
• W3168291254 hasConceptScore W3168291254C2780309369 @default.
• W3168291254 hasConceptScore W3168291254C2908539429 @default.
• W3168291254 hasConceptScore W3168291254C44249647 @default.
• W3168291254 hasConceptScore W3168291254C673006 @default.
• W3168291254 hasConceptScore W3168291254C71924100 @default.
• W3168291254 hasConceptScore W3168291254C90924648 @default.
• W3168291254 hasConceptScore W3168291254C95190672 @default.
• W3168291254 hasLocation W31682912541 @default.
• W3168291254 hasOpenAccess W3168291254 @default.
• W3168291254 hasPrimaryLocation W31682912541 @default.
• W3168291254 hasRelatedWork W10361015 @default.
• W3168291254 hasRelatedWork W12111482 @default.
• W3168291254 hasRelatedWork W18268121 @default.
• W3168291254 hasRelatedWork W18977415 @default.
• W3168291254 hasRelatedWork W19721516 @default.
• W3168291254 hasRelatedWork W5056314 @default.
• W3168291254 hasRelatedWork W7529559 @default.
• W3168291254 hasRelatedWork W13698670 @default.
• W3168291254 hasRelatedWork W19522811 @default.
• W3168291254 hasRelatedWork W19652210 @default.
• W3168291254 isParatext "false" @default.
• W3168291254 isRetracted "false" @default.
• W3168291254 magId "3168291254" @default.
• W3168291254 workType "article" @default.